155 related articles for article (PubMed ID: 7997708)
1. Analysing survival in the presence of an auxiliary variable.
Finkelstein DM; Schoenfeld DA
Stat Med; 1994 Sep; 13(17):1747-54. PubMed ID: 7997708
[TBL] [Abstract][Full Text] [Related]
2. Sequential monitoring of clinical trials with multiple survival endpoints.
Williams PL
Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205
[TBL] [Abstract][Full Text] [Related]
3. Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research.
Fleming TR; Prentice RL; Pepe MS; Glidden D
Stat Med; 1994 May; 13(9):955-68. PubMed ID: 8047747
[TBL] [Abstract][Full Text] [Related]
4. Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
Neaton JD; Wentworth DN; Rhame F; Hogan C; Abrams DI; Deyton L
Stat Med; 1994 Oct 15-30; 13(19-20):2107-25. PubMed ID: 7846414
[TBL] [Abstract][Full Text] [Related]
5. Evaluating surrogate markers of clinical outcome when measured with error.
Dafni UG; Tsiatis AA
Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
[TBL] [Abstract][Full Text] [Related]
6. On optimal treatment regimes selection for mean survival time.
Geng Y; Zhang HH; Lu W
Stat Med; 2015 Mar; 34(7):1169-84. PubMed ID: 25515005
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data.
Faucett CL; Schenker N; Taylor JM
Biometrics; 2002 Mar; 58(1):37-47. PubMed ID: 11892691
[TBL] [Abstract][Full Text] [Related]
8. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of interventions on incubation of AIDS as measured by secular increases within a population.
Hoover DR; Muñoz A; He Y; Taylor JM; Kingsley L; Chmiel JS; Saah A
Stat Med; 1994 Oct 15-30; 13(19-20):2127-39. PubMed ID: 7846415
[TBL] [Abstract][Full Text] [Related]
10. Cox regression with dependent error in covariates.
Huang Y; Wang CY
Biometrics; 2018 Mar; 74(1):118-126. PubMed ID: 28682458
[TBL] [Abstract][Full Text] [Related]
11. Advances in medical statistics arising from the AIDS epidemic.
Becker NG; Marschner IC
Stat Methods Med Res; 2001 Apr; 10(2):117-40. PubMed ID: 11338334
[TBL] [Abstract][Full Text] [Related]
12. On the use of auxiliary data to estimate the survival function and its variance: an application to acquired immunodeficiency syndrome.
Flandre P
J Clin Epidemiol; 1996 Aug; 49(8):899-905. PubMed ID: 8699211
[TBL] [Abstract][Full Text] [Related]
13. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
Dagne GA
J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
[TBL] [Abstract][Full Text] [Related]
15. A class of permutation tests for stratified survival data.
Shih JH
Biometrics; 1999 Dec; 55(4):1156-61. PubMed ID: 11315062
[TBL] [Abstract][Full Text] [Related]
16. Multiple imputation for interval censored data with auxiliary variables.
Hsu CH; Taylor JM; Murray S; Commenges D
Stat Med; 2007 Feb; 26(4):769-81. PubMed ID: 16755528
[TBL] [Abstract][Full Text] [Related]
17. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
Cole SR; Hernán MA; Robins JM; Anastos K; Chmiel J; Detels R; Ervin C; Feldman J; Greenblatt R; Kingsley L; Lai S; Young M; Cohen M; Muñoz A
Am J Epidemiol; 2003 Oct; 158(7):687-94. PubMed ID: 14507605
[TBL] [Abstract][Full Text] [Related]
18. Partly conditional survival models for longitudinal data.
Zheng Y; Heagerty PJ
Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
[TBL] [Abstract][Full Text] [Related]
19. Statistical models for prevalent cohort data.
Wang MC; Brookmeyer R; Jewell NP
Biometrics; 1993 Mar; 49(1):1-11. PubMed ID: 8513095
[TBL] [Abstract][Full Text] [Related]
20. Frailty models for arbitrarily censored and truncated data.
Huber-Carol C; Vonta I
Lifetime Data Anal; 2004 Dec; 10(4):369-88. PubMed ID: 15690991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
